Update on Giant Cell Arteritis: Essential Information for Ophthalmologists

Giant cell arteritis (GCA) is an important cause of irreversible vision loss in the elderly population. For any physician, making this diagnosis can be difficult due to the highly variable clinical presentation of this large-vessel vasculitis. The 1990 American College of Rheumatology (ACR) classification criteria for GCA are frequently used, however, they were developed to classify GCA patients vs those with other forms of vasculitis and are not true diagnostic criteria. Despite the high predilection of GCA for ocular circulations, the original 1990 criteria did not include any signs or symptoms related to vision. The classification criteria were updated by the ACR and European Alliance of Associations for Rheumatology (EULAR) in 2022 with the significant inclusion of “Sudden vision loss” (Table 1).

Authors

Institutions

Publication Details

Journal
Canadian Eye Care Today
Published
2024-08-30
DOI
https://doi.org/10.58931/cect.2024.3348
Primary Topic
Vasculitis and related conditions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Update on Giant Cell Arteritis: Essential Information for Ophthalmologists

Laura Donaldson
Canadian Eye Care Today
Vasculitis and related conditions
article

Update on Giant Cell Arteritis: Essential Information for Ophthalmologists

Laura Donaldson
article en

Abstract

Giant cell arteritis (GCA) is an important cause of irreversible vision loss in the elderly population. For any physician, making this diagnosis can be difficult due to the highly variable clinical presentation of this large-vessel vasculitis. The 1990 American College of Rheumatology (ACR) classification criteria for GCA are frequently used, however, they were developed to classify GCA patients vs those with other forms of vasculitis and are not true diagnostic criteria. Despite the high predilection of GCA for ocular circulations, the original 1990 criteria did not include any signs or symptoms related to vision. The classification criteria were updated by the ACR and European Alliance of Associations for Rheumatology (EULAR) in 2022 with the significant inclusion of “Sudden vision loss” (Table 1).

Canadian Eye Care Today
McMaster University (CA)
Reduced inequalities
Openalex Percentile: Top 74%
Vasculitis and related conditions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.